Clinical Trials Browser

Approved for marketing × Carcinoma, Basal Cell × Clear all

NCT06132191 2025-11-20

Expanded Access Use of Cemiplimab in Patients With Solid Tumors

Approved for marketing

DermatologicThoracic

Carcinoma, Basal Cell, Carcinoma, Non-Small-Cell Lung

NCT01160250 2015-08-06

A Study of Vismodegib (GDC-0449) in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma

Approved for marketing

Carcinoma, Basal Cell